Evidence-based Pediatric Obstructive Sleep Apnea Detection

Status Enrolling by invitation

Clinical Trial Summary

The goal of this clinical trial is to test whether a health communication message (infographic about obstructive sleep apnea; OSA) seen by parents whose children have OSA symptoms will be helpful in identifying children with OSA. The main questions it aims to answer are: - Will parents who see this health communication message be more likely to talk to their child's health care provider about OSA? - Does the use of a health communication message help health care systems identify more children with OSA? Participants are parents and children who are patients in a specific health care center. As part of clinical care, parents will answer screening questions about OSA symptoms (e.g., snoring, sleepiness) before their child's primary care visit. If their child has OSA symptoms, the health care provider will receive an alert suggesting further evaluation and possible referral for a sleep study or to a specialist. In this study, children with OSA symptoms whose parents answer screening questions will be randomized to one of two conditions: 1) Health communication message (parent sees message before their child's visit with a primary care provider); or 2) Usual care (no information about OSA or their child's risk). Researchers will compare groups to see if the health communication message helps identify more children with OSA.

Clinical Trial Description

Many children with obstructive sleep apnea (OSA) are not identified and thus do not receive treatment. In a previous study, the investigators found that a clinical decision support system helped primary care providers (PCPs) identify children with obstructive sleep apnea (OSA). In this system, parents of children report on possible OSA symptoms (e.g., snoring, sleepiness) in their child before the visit. If the child has OSA symptoms, the PCP receives an alert during the visit recommending further evaluation and a possible referral for a sleep study or to see a specialist. While this system helped increase the number of children with OSA symptoms who received a referral, many children remained unidentified. The goal of this study is to see whether involving parents in the system can identify even more children. In this study, the investigators propose to test the impact of a health communication message, designed to educate and activate parents about their child's risk for OSA. This message is an infographic that helps parents recognize nighttime symptoms of OSA and how these nighttime symptoms may be impacting their child during the day. If a child has OSA symptoms, parents would view this infographic before their child's PCP visit and could discuss OSA with their child's PCP. For children with OSA symptoms, their parents will be randomized to either: 1) view the health communication message, or; 2) usual care, in which parents are not given any additional information about OSA or their child's risk prior to the appointment. In both cases, PCPs will receive a prompt indicating that the child is at risk for OSA. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05908110
Study type	Interventional
Source	Indiana University
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	June 21, 2023
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02987985` - Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy	Phase 3
Active, not recruiting	`NCT05154214` - Surgical Treatment of Children With OSA and Small Tonsils or Down Syndrome
Recruiting	`NCT06367400` - Validation of Pediatric Sleep Questionnaire on a Swedish Cohort
Completed	`NCT03134300` - Cytokine Persistence as a Marker of Inflammation in the at Risk, Low Socioeconomic Status Pediatric Population	N/A
Not yet recruiting	`NCT06093802` - Endoscopic Classification and DISE-Guided Surgery in Pediatric Obstructive Sleep-Disordered Breathing.	N/A
Recruiting	`NCT05115968` - Single Cell Sequencing of Tonsillar Tissue in Children With OSA
Recruiting	`NCT03370731` - Surgical Versus Nonsurgical Treatment on Quality of Life for Children With Controversial OSA Diagnoses	N/A
Completed	`NCT02247167` - Endothelial Dysfunction and Oxidative Stress in Children With Sleep Disordered Breathing.	Phase 1/Phase 2
Completed	`NCT05499455` - SleepPOSAtive Trial	N/A
Recruiting	`NCT05382494` - Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children	Phase 4
Recruiting	`NCT03995628` - Steroids and Pain Control After Tonsillectomy	Phase 2
Recruiting	`NCT04732572` - Brain Tissue Integrity and Autonomic Function Alterations in Childhood OSA and ADHD, and After Adenotonsillectomy.	N/A
Active, not recruiting	`NCT04349397` - Use of Analgesics and Pain Scores After Pediatric Adenotonsillectomy
Completed	`NCT04328402` - Factors Correlated With Obstructive Sleep Apnea in Children and Adolescents

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.